Article Information
History
- August 5, 2020.
Article Versions
- Version 1 (August 1, 2020 - 23:06).
- Version 2 (August 4, 2020 - 12:41).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Marah G. Chibwana1,§,
- Khuzwayo C. Jere1,2,§,
- Raphael Kamn’gona1,
- Jonathan Mandolo1,
- Vincent Katunga-Phiri1,
- Dumizulu Tembo1,
- Ndaona Mitole1,
- Samantha Musasa3,
- Simon Sichone1,
- Agness Lakudzala1,
- Lusako Sibale1,
- Prisca Matambo1,
- Innocent Kadwala1,
- Rachel L. Byrne4,
- Alice Mbewe1,
- Marc Y. R. Henrion1,4,
- Ben Morton1,4,
- Chimota Phiri5,
- Jane Mallewa3,
- Henry C Mwandumba1,4,
- Emily R. Adams4,
- Stephen B. Gordon1,4,* and
- Kondwani C. Jambo1,4,*,#
- 1Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi
- 2Centre for Global Vaccine Research, Institute of Infection, Veterinary Ecological Sciences, University of Liverpool, Liverpool, UK
- 3Department of Medicine, College of Medicine, University of Malawi, Blantyre, Malawi
- 4Liverpool School of Tropical Medicine, L3 5QA, Liverpool, United Kingdom
- 5Ministry of Health, Queen Elizabeth Central Hospital, Blantyre, Malawi
- ↵#Corresponding author: Kondwani C. Jambo (kjambo{at}mlw.mw)
↵§ Authors contributed equally.